References
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. February 7, 2020. DOI:10.1001/jama.2020.1585
- Remuzzi A , Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395(10231):1225–1228.
- Mirco Nacoti AC , Giupponi A , Brambillasca P , et al. Carlo, montaguti: at the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Cat Innovations Care Delivery. 2020;1:2.
- Grasselli G , Pesenti A , Cecconi M . Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323(16):1545.
- al. DGe: covid19ita; 2020 Mar [cited 2020 Mar 24 ]. https://r-ubesp.dctv.unipd.it/shiny/covid19ita/(Last
- European Centre for Disease Prevention and Control . Risk assessment on COVID-19; 2020 March 25 [cited Mar 26 ]. https://www.ecdc.europa.eu/en/current-risk-assessment-novel-coronavirus-situation.
- WorlHealtOrganization: clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected; 2020 [cited 2020 Mar 23 .
- Organization WH: disease commodity package - Novel Coronavirus (COVID-19); 2020 Mar [cited 2020 Mar 25 ]. https://www.who.int/publications-detail/disease-commodity-package—novel-coronavirus-(ncov)
- Garzotto F , Ostermann M , Martin-Langerwerf D , et al. The dose response multicentre investigation on fluid assessment (DoReMIFA) in critically ill patients. Crit Care. 2016;20(1):196.
- Bouadma L , Lescure FX , Lucet JC , et al. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med. 2020;46:579–582.
- Zhou F , Yu T , Du R , et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
- Huang C , Wang Y , Li X , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
- Ankawi G , Neri M , Zhang J , et al. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls. Crit Care. 2018;22(1):262.
- TheEuropeanParliament-and-the-Council-of-the-EuropeanUnion: EU directive 2017/745; 2020 [cited 2020 Mar 23 ]. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0745
- FoodAndDrugAdministration: enforcement policy for ventilators and accessories and other respiratory devices during the coronavirus disease 2019 (COVID-19) public health emergency; 2020 Mar [cited 2020 Mar 25]. https://www.fda.gov/media/136318/download
- Administration FaD: coronavirus disease 2019 (COVID-19) emergency use authorizations for medical devices; 2020 Mar [cited Mar 31 ]. https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations#covid19ventilators.
- foundation ASoAaAPs: APSF/ASA guidance on purposing anesthesia machines as ICU ventilators; 2020 Mar. [cited 2020 Mar 25 ]. https://www.asahq.org/in-the-spotlight/coronavirus-covid-19-information/purposing-anesthesia-machines-for-ventilators.
- Medicines-and-healthcare-products-regulatory-agency-MHRA: exemptions from Devices regulations during the coronavirus (COVID-19) outbreak; 2020 [cited 2020 Mar 25 ]. https://www.gov.uk/guidance/exemptions-from-devices-regulations-during-the-coronavirus-covid-19-outbreak.
- MHRA M-a-H-P-R-A: specification for ventilators to be used in UK hospitals during the coronavirus (COVID-19) outbreak; 2020 Mar [cited 2020 Mar 24 ]. https://www.gov.uk/government/publications/specification-for-ventilators-to-be-used-in-uk-hospitals-during-the-coronavirus-covid-19-outbreak
- Guidance on medical devices, active implantable medical devices and in vitro diagnostic medical devices in the COVID-19 context
- FoodAndDrugAdministration: coronavirus (COVID-19) Update: FDA allows expanded use of devices to monitor patients’ vital signs remotely; 2020 [cited 2020 Mar 24 ]. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-allows-expanded-use-devices-monitor-patients-vital-signs-remotely.
- Liu C , Mao Z , Kang H , et al. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Crit Care. 2016;20(1):144.
- Patel BK , Wolfe KS , Pohlman AS , et al. Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2016;315(22):2435–2441.
- Lodi CA , Vasta A , Hegbrant MA , et al. Multidisciplinary evaluation for severity of hazards applied to hemodialysis devices: an original risk analysis method. Clin J Am Soc Nephrol. 2010;5(11):2004–2017.
- COVID-19: All haemofiltration systems including machines and accessories – serious risks if users don’t follow manufacturer instructions for set-up (MDA/2020/013)